Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction

计划入组 39 人 · 首次发布于 2011 年 6 月 7 日

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function

计划入组 32 人 · 首次发布于 2011 年 6 月 7 日

A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects

计划入组 68 人 · 首次发布于 2019 年 11 月 6 日

TX-200

EGTX-002

CNTX-6016

Ente Ospedaliero Cantonale

Switzerland

Ente Ospedaliero Ospedali Galliera

Italy

Ente Ospedaliero Cantonale (EOC)

Switzerland

Entera Bio to Present Phase 2 Osteoporosis Data and Next-Generation Oral Peptide Programs at September 2025 Conferences

Entera Bio Announces Positive Updates on Oral Peptide Programs and Q3 2024 Financial Results

UK Launches £18.8 Million Initiative to Transform Nuclear Waste into Precision Cancer Therapies